COVID-19 Vaccination in Italian Children: The Limits of Parental Rights
- PMID: 35626802
- PMCID: PMC9139867
- DOI: 10.3390/children9050625
COVID-19 Vaccination in Italian Children: The Limits of Parental Rights
Abstract
SARS-CoV-2 vaccination campaigns initially targeted the adult population. After the authorization of the main agencies, including the EMA (European Medicines Agency), the European Vaccination Plan now involves young people between the ages of 12-17 and 5-11. In assessing the child's "best interests", the refusal of vaccination by parents or guardians, in addition to the increased circulation of the virus, is responsible for the risk of social distancing. This reduction in social contacts, particularly during very sensitive ages such as adolescence, has been linked to the increased incidence of psychiatric illness, a significant reason for extending vaccination against SARS-CoV-2 in these younger children. One may consider that government should issue a law that allows the child to decide on the vaccination plan, even without the consent of the parents or guardians, without the need for a judge's ruling. The availability of the child should be the point of reference, according to the National Bioethics Committee, for consent to vaccination. The authors investigate the subject in depth in order to counteract vaccination hesitation, and promote the dissemination of correct scientific information, using every different possible communication tool, as well as social networks and schools.
Keywords: SARS-CoV-2; children; parental consent; public health; social responsibility; vaccination strategies; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Su T.-P., Lien T.-C., Yang C.-Y., Su Y.L., Wang J.-H., Tsai S.-L., Yin J.-C. Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS caring unit during outbreak: A prospective and periodic assessment study in Taiwan. J. Psychiatr. Res. 2007;41:119–130. doi: 10.1016/j.jpsychires.2005.12.006. - DOI - PMC - PubMed
-
- Lustig Y., Zuckerman N., Nemet I., Atari N., Kliker L., Regev-Yochay G., Sapir E., Mor O., Alroy-Preis S., Mendelson E., et al. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Eurosurveillance. 2021;26:2100557. doi: 10.2807/1560-7917.ES.2021.26.26.2100557. - DOI - PMC - PubMed
-
- Luxi N., Giovanazzi A., Capuano A., Crisafulli S., Cutroneo P.M., Fantini M.P., Ferrajolo C., Moretti U., Poluzzi E., Raschi E., et al. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf. 2021;44:1247–1269. doi: 10.1007/s40264-021-01131-6. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
